The dictates of the in vitro diagnostic regulation (IVDR) and “bureaucratic” issues are dampening the industry’s innovation ...

The market is projected to expand at a compound annual growth rate of 6% from 2024 to 2034. Growing clinical evidence is ...

Siemens has announced plans to ‘deconsolidate’ its remaining stake in Siemens Healthineers by transferring 30% of shares to ...

Biogen has completed the acquisition of Alcyone Therapeutics, for $85m upfront payment, to boost central nervous system (CNS) ...

Zimmer Biomet has received 510(k) clearance from the US Food and Drug Administration (FDA) for ROSA Knee with OptimiZe ...

Clairity has concluded a $43m funding round, allowing it to advance commercialisation for its AI-powered breast cancer ...

Beacon Biosignals has secured $86m in a Series B funding round aimed at expanding its neurodiagnostic dataset and furthering ...

Boston Scientific has entered an agreement with Siemens Healthineers to push forward commercialisation activities for the ...

InBrain Neuroelectronics has partnered with Microsoft to explore how it can advance precision neurology by applying agentic ...

Myriad Genetics has broadened the scope of its MyRisk Hereditary Cancer Test for germline testing, adding genes.

RadNet has announced the acquisition of cloud-native healthcare image management solutions provider CIMAR UK. The company ...

Owlet has partnered with Rhapsody to integrate data from its at-home pulse oximeter, BabySat, directly into the patient’s ...